Enliven Therapeutics Inc (ELVN)

Nov 21, 2025

Enliven Therapeutics Insider Sold Shares Worth $279,155, According to a Recent SEC Filing - MarketScreener

Nov 21, 2025

Nov 21, 2025

Will Enliven Therapeutics Inc. stock outperform international peersWeekly Market Report & AI Enhanced Trade Execution Alerts - newser.com

Nov 21, 2025

Nov 20, 2025

How Enliven Therapeutics Inc. stock reacts to Fed rate cutsGlobal Markets & Daily Technical Forecast Reports - newser.com

Nov 20, 2025

Nov 20, 2025

Why Enliven Therapeutics Inc. stock is favored by pension fundsWall Street Watch & Low Drawdown Investment Ideas - newser.com

Nov 20, 2025

Nov 20, 2025

What hedge fund activity signals for Enliven Therapeutics Inc. stock2025 Market Outlook & Weekly Top Gainers Alerts - newser.com

Nov 20, 2025

Nov 19, 2025

Is Enliven Therapeutics Inc. stock positioned well for digital economyMarket Risk Analysis & Expert-Curated Trade Recommendations - newser.com

Nov 19, 2025

Nov 19, 2025

Is Enliven Therapeutics Inc. stock a contrarian buy2025 Investor Takeaways & AI Powered Market Entry Ideas - newser.com

Nov 19, 2025

Nov 19, 2025

Enliven Therapeutics CEO Kintz sells $272k in shares By Investing.com - Investing.com Canada

Nov 19, 2025

Nov 19, 2025

What analyst consensus says on Enliven Therapeutics Inc. stockJuly 2025 Analyst Calls & Free Fast Gain Swing Trade Alerts - newser.com

Nov 19, 2025

Nov 18, 2025

Enliven Therapeutics Inc (ELVN) can make a big difference with a little luck - Setenews

Nov 18, 2025

Nov 18, 2025

Enliven Therapeutics: Notable Early Signals, But Too Many Assumptions To Justify A Buy - Seeking Alpha

Nov 18, 2025

Nov 17, 2025

Enliven Therapeutics CEO and CFO participate in Jefferies conference - Traders Union

Nov 17, 2025

Nov 17, 2025

Does Enliven Therapeutics, Inc. (ELVN) Have the Potential to Rally 87.49% as Wall Street Analysts Expect? - Yahoo Finance

Nov 17, 2025

Nov 17, 2025

What is Lifesci Capital’s Forecast for ELVN FY2025 Earnings? - Defense World

Nov 17, 2025

Nov 16, 2025

Price-Driven Insight from (ELVN) for Rule-Based Strategy - news.stocktradersdaily.com

Nov 16, 2025

Nov 16, 2025

Published on: 2025-11-16 16:06:17 - newser.com

Nov 16, 2025

Nov 16, 2025

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Receives $41.20 Average Price Target from Brokerages - Defense World

Nov 16, 2025

Nov 16, 2025

Applying sector rotation models to Enliven Therapeutics Inc.Portfolio Value Report & Fast Moving Stock Trade Plans - newser.com

Nov 16, 2025

Nov 15, 2025

Can Enliven Therapeutics Inc. stock deliver strong Q4 earnings2025 Price Momentum & Growth Oriented Trade Recommendations - newser.com

Nov 15, 2025

Nov 15, 2025

Enliven Therapeutics (NASDAQ:ELVN) Rating Increased to Hold at Wall Street Zen - Defense World

Nov 15, 2025

Nov 13, 2025

Is Enliven Therapeutics Inc. stock a safe haven assetJuly 2025 Macro Moves & Free Expert Verified Stock Movement Alerts - newser.com

Nov 13, 2025

Nov 13, 2025

Published on: 2025-11-13 21:13:49 - newser.com

Nov 13, 2025

Nov 13, 2025

Automated trading signals detected on Enliven Therapeutics Inc.Portfolio Performance Summary & Step-by-Step Swing Trade Plans - newser.com

Nov 13, 2025

Nov 13, 2025

Enliven Therapeutics Inc. stock daily chart insights2025 Momentum Check & Free Community Supported Trade Ideas - newser.com

Nov 13, 2025

Nov 13, 2025

Decoding Enliven Therapeutics Inc (ELVN): A Strategic SWOT Insig - GuruFocus

Nov 13, 2025

Nov 13, 2025

Enliven Therapeutics Reports Q3 2025 Financial Results - TipRanks

Nov 13, 2025

Nov 12, 2025

Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update - PR Newswire

Nov 12, 2025

Nov 12, 2025

Published on: 2025-11-12 18:07:48 - newser.com

Nov 12, 2025

Nov 12, 2025

Enliven Therapeutics Keeps Moving Forward As Losses Narrow And Cash Holds Strong - Finimize

Nov 12, 2025